loadpatents
name:-0.022879838943481
name:-0.010419130325317
name:-0.0061709880828857
Osada; Takuya Patent Filings

Osada; Takuya

Patent Applications and Registrations

Patent applications and USPTO patent grants for Osada; Takuya.The latest application filed is for "x-ray psoralen activated cancer therapy (x-pact)".

Company Profile
6.9.19
  • Osada; Takuya - Durham NC
  • Osada; Takuya - Chapel Hill NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
X-ray Psoralen Activated Cancer Therapy (x-pact)
App 20220226666 - Oldham; Mark ;   et al.
2022-07-21
X-ray psoralen activated cancer therapy (X-PACT)
Grant 11,305,131 - Oldham , et al. April 19, 2
2022-04-19
Cancer vaccines and methods of delivery
Grant 11,253,580 - Lyerly , et al. February 22, 2
2022-02-22
Vaccines against antigens involved in therapy resistance and methods of using same
Grant 11,235,043 - Lyerly , et al. February 1, 2
2022-02-01
X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments
Grant 11,207,409 - Bourke, Jr. , et al. December 28, 2
2021-12-28
Vaccines Against Antigens Involved In Therapy Resistance And Methods Of Using Same
App 20210330773 - Lyerly; Herbert K. ;   et al.
2021-10-28
VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAME
App 20210077606 - Lyerly; Herbert K. ;   et al.
2021-03-18
Vaccines Against An Oncogenic Isoform Of Esr1 And Methods Of Using The Same
App 20210069309 - Lyerly; Herbert K. ;   et al.
2021-03-11
Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same
Grant 10,842,857 - Lyerly , et al. November 24, 2
2020-11-24
Vaccines against an oncogenic isoform of ESR1 and methods of using the same
Grant 10,842,855 - Lyerly , et al. November 24, 2
2020-11-24
X-ray Psoralen Activated Cancer Therapy (x-pact)
App 20200009398 - OLDHAM; Mark ;   et al.
2020-01-09
Vaccines against HER3 antigens and methods of using the same
Grant 10,487,143 - Lyerly , et al. Nov
2019-11-26
X-ray psoralen activated cancer therapy (X-PACT)
Grant 10,441,810 - Oldham , et al. Oc
2019-10-15
Cancer Vaccines And Methods Of Delivery
App 20190022204 - Lyerly; Herbert K. ;   et al.
2019-01-24
X-ray Psoralen Activated Cancer Therapy (x-pact) With Associated Treatments
App 20180344850 - BOURKE, JR.; Frederic A. ;   et al.
2018-12-06
VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAME
App 20180344824 - Lyerly; Herbert K. ;   et al.
2018-12-06
Vaccines Against An Oncogenic Isoform Of Esr1 And Methods Of Using The Same
App 20180326030 - Lyerly; Herbert K. ;   et al.
2018-11-15
Vaccines Against Antigens Involved In Therapy Resistance And Methods Of Using Same
App 20180311329 - Lyerly; Herbert K. ;   et al.
2018-11-01
Her3 Vaccine Vector Compositions And Methods Of Using The Same
App 20180282736 - Lyerly; Herbert K. ;   et al.
2018-10-04
Vaccines against antigens involved in therapy resistance and methods of using same
Grant 9,956,276 - Lyerly , et al. May 1, 2
2018-05-01
Vaccines Against Her3 Antigens And Methods Of Using The Same
App 20180094050 - Lyerly; Herbert K. ;   et al.
2018-04-05
VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAME
App 20170196953 - Lyerly; Herbert K. ;   et al.
2017-07-13
Vaccines Against An Oncogenic Isoform Of Esr1 And Methods Of Using The Same
App 20170196952 - Lyerly; Herbert K. ;   et al.
2017-07-13
X-ray Psoralen Activated Cancer Therapy (x-pact)
App 20170157418 - OLDHAM; Mark ;   et al.
2017-06-08
Compositions And Methods For Modulating And Redirecting Immune Responses
App 20170015758 - HAMMOND; Scott A. ;   et al.
2017-01-19
Vaccines Against Antigens Involved In Therapy Resistance And Methods Of Using Same
App 20140377261 - Lyerly; Herbert K. ;   et al.
2014-12-25
Treatment Of Wnt/frizzled-related Diseases
App 20130005802 - Chen; Wei ;   et al.
2013-01-03
Inhibition of breast carcinoma stem cell growth and metastasis
App 20070297983 - Ferrone; Soldano ;   et al.
2007-12-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed